KF
GOSS icon

Krilogy Financial’s Gossamer Bio GOSS Stock Holding History

Krilogy Financial’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76K Sell
10,725
-5,886
-35% -$1.64K ﹤0.01% 1071
2026
Q1 		$7.27K Buy
+16,611
New +$26.1K ﹤0.01% 980

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Krilogy Financial's GOSS Position: Q2 2026 in Review

Krilogy Financial reduced its Gossamer Bio (GOSS) stake by 35% in Q2 2026, selling an estimated $1.64K and leaving 10,725 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

Krilogy Financial first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.27K in Q1 2026. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Krilogy Financial held 10,725 shares of Gossamer Bio worth $1.76K as of Q2 2026.
  • Krilogy Financial sold 5,886 Gossamer Bio shares in Q2 2026, an estimated $1.64K.
  • Gossamer Bio made up ﹤0.01% of Krilogy Financial's portfolio in Q2 2026, its #1071 holding.
  • Krilogy Financial first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • Krilogy Financial's Gossamer Bio position peaked at $7.27K in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.